EI
DVAX

EAM Investors’s Dynavax Technologies DVAX Stock Holding History

EAM Investors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-215,420
Closed -$4.14M – 303
2021
Q3 		$4.14M Buy
+215,420
New +$2.86M 0.7% 18
2017
Q4 		– Sell
-237,938
Closed -$5.12M – 310
2017
Q3 		$5.12M Buy
+237,938
New +$3.76M 0.68% 27
2016
Q1 		– Sell
-159,125
Closed -$3.84M – 306
2015
Q4 		$3.84M Buy
159,125
+654
+0.4% +$16.4K 0.5% 55
2015
Q3 		$3.89M Sell
158,471
-84,415
-35% -$2.39M 0.62% 22
2015
Q2 		$5.69M Buy
242,886
+55,207
+29% +$1.2M 0.67% 12
2015
Q1 		$4.21M Buy
+187,679
New +$3.6M 0.49% 41

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

EAM Investors's DVAX Position: Q4 2021 in Review

EAM Investors sold out of Dynavax Technologies (DVAX) in Q4 2021, closing a stake of 215,420 shares — an estimated $4.14M sold.

EAM Investors first reported a position in DVAX in Q1 2015 and held it in 6 quarters. The position peaked at $5.69M in Q2 2015. 200 funds tracked by Wall St. Rank hold DVAX as of Q4 2021.

  • EAM Investors reported no remaining Dynavax Technologies position as of Q4 2021 after selling out during the quarter.
  • EAM Investors sold 215,420 Dynavax Technologies shares in Q4 2021, an estimated $4.14M.
  • EAM Investors first reported a position in Dynavax Technologies in Q1 2015 and held it in 6 quarters.
  • EAM Investors's Dynavax Technologies position peaked at $5.69M in Q2 2015.
  • 200 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2021.

Based on EAM Investors's 13F filing for Q4 2021, filed 11 Feb 2022.